Welcome to the Cellebrite First Quarter 2024 Financial Results Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for your questions following the presentation. [Operator Instructions]. I would now like to turn the call over to your first speaker today, Mr. Andrew Kramer. Mr. Kramer, the floor is yours.

Thank you very much, Leo. Good morning, good afternoon. Welcome to Cellebrite's first quarter 2024 financial results conference call. Joining me today from just outside of Tel Aviv are Yossi Carmil, Cellebrite's CEO, and Dana Gerner, Cellebrite's CFO. There is a slide presentation that accompanies our prepared remarks. Please advance the slides in the webcast viewer to follow our commentary, we will call out the slide number we are referring to in our remarks. This call is being recorded and a replay of the recording will be made available on our website shortly after the call. Starting with Slide number 2, a copy of today's press release and financial statements, including GAAP to non-GAAP reconciliations, slide presentation and the quarterly financial tables and supplemental historical financial information for the first quarter of 2024 and each quarter of 2023 and 2022 are available on the Investor Relations website at investors.cellebrite.com. Also, unless stated otherwise, our discussion for the first quarter 2022 -- sorry, 2024 financial metrics, as well as the financial metrics provided in our outlook, will be done on a non-GAAP basis only, and all historical comparisons are with the first quarter of 2023 unless otherwise noted. In addition, please note that the statements made during this call that are not statements of historical fact constitute forward-looking statements. All forward-looking statements are subject to risks and uncertainties and other factors that could cause matters expressed or implied by those forward-looking statements not to occur. They could also cause the actual results to differ materially from historical results and/or from forecasts. Some of these forward-looking statements are discussed under the heading Risk Factors and elsewhere in the Company's annual report on Form 20-F filed with the SEC on March 21, 2024 and as amended on April 12th, 2024. The Company does not undertake to update any forward-looking statements to reflect future events or circumstances. Slide number 3 provides the agenda for today's call. And as you'll hear, we started the 2024 off on a positive note with another very solid quarter. We move forward with good momentum and are excited about the opportunities we see ahead to further expand our business this year. With that said, I'd like to turn the call over to Yossi Carmil, Cellebrite's CEO.

Thank you, Andy. And thank you all for joining us today. The financial results highlighted on Slide 4 demonstrate that Cellebrite is off to a very solid start in 2024. We delivered a strong first quarter performance anchored by the further expansion of our business, improved profitability compared with the same quarter one year ago, and meaningful strategic progress. I have to say it is rewarding to see our solutions are making a tangible difference in accelerating justice around the world. While I plan to share more about the market opportunity, our strategy, our achievements, and our outlook, I would like to turn now to Slide 4 to briefly recap our Q1 results and selected KPIs. And more specifically, ARR grew 27% to $331.8 million. We continue to see strong ARR growth globally and our Q1 ARR expansion is primarily driven by our success in expanding existing customers relationship, which is consistent with historical trends. The total revenue of $89.6 million increased 26% on the strength of a 29% increase in subscription software revenue. Adjusted EBITDA was $17.6 million, or 20% on a margin basis and we reported non-GAAP earnings per share of $0.08. We also ended the first quarter with cash deposits and investment totaling approximately $347 million, a $15.5 million increase since the end of 2023. After trailing 12 months, our ARR growth rate and adjusted EBITDA margin trended above a baseline target of Rule of 45. Turning to Slide 5. As most of you know, Cellebrite hosted its first ever Investor Day in late March this year. This was a great opportunity to provide our analysts and shareholders with a deeper dive into our business and our bright future. During this event, we highlighted the underlying trends, Cellebrite overarching strategy, our compelling Case-to-Closure platform and flagship solutions,…

Thank you, Yossi. As noted in Yossi's comments earlier, our Q1 results demonstrate that we are off to a very solid start for the year. We delivered revenue above our targets, ARR at the higher end of our plans and stronger than anticipated adjusted EBITDA. So let's begin the review of the Q1 on Slide 9. We reported first quarter revenue of $89.6 million, an increase of 26%, a 29% increase in subscription revenue was partially offset by a more moderate increase of hardware sales within our other non-recurring revenue and a slight decline of our professional services revenue. Within professional services, the decline in advanced services revenue is correlated with the growth in higher sales of our advanced lawful access offering, and this decline was mostly offset by the growth in training and certification. Overall, subscription revenue represented 88% of total revenue and we expect that it will continue to trend within the mid-to-high 80% range over the coming quarters. Slide 10 details our ARR growth drivers. Our ARR grew 27% year-on-year to $332 million at the end of March 2024. We maintained healthy growth retention of approximately 91% for the first quarter. Our ARR growth was driven primarily by existing customers expansion, with new logos contributing modestly, which is consistent with our growth strategy. In terms of ARR growth by product area, we have continued to see customers expand their use of our Inseyets collect and review solution. This growth is complemented by our continued progress cross selling and upselling our evidence management and AI-powered investigative analytics. Our geographic mix for ARR for the 12 months ended on March 31st, '24 was generally in line with historical trends, with the Americas representing our largest geography at 52% of total, followed by EMEA at 36% and Asia Pacific at…

[Operator Instructions] Our first question is coming from Shaul Eyal of TD Cowen.

Thank you. Good afternoon, good morning. Congrats on 1Q results. Yossi the business seems to be kicking on all cylinders. I wanted to start by asking on the potential business upside you could be seeing from FedRAMP that you guys have announced earlier in March.

Shaul, first of all, thank you for that. Indeed, in mid-March 2024, we announced the launch of the process to authorize our SaaS offering with FedRAMP. Now, FedRAMP is an important initiative I would say for us and in the context of potentially doubling our total addressable market, specifically in the federal market space in the United States and over the longer term, clearly and opening, I would say substantial opportunity over the coming years, clearly benefit of accessing additional buying centers within the already existing logo and secure higher budgets in 2025. The FedRAMP represents an area of significant investment during 2024. This is something which is important to emphasize, which by the way had been factored into our 2024 outlook and the FedRAMP will initially apply to our Guardian platform and infrastructure that supports the Guardian. But once the work is done, it will make it easier to deliver other cloud enabled offering of our FedRAMP certified platform. And maybe one thing that needs to be emphasized, important element -- FedRAMP is an important element of a broader plan to expand the business with the federal customers. And maybe in that context just emphasizing that it will contribute clearly to value proposition our C2C platform in the context of an end-to-end and clearly long, broad Runway for substantial ARR growth in the future.

Understood. Maybe kind of you front run me on -- maybe double clicking on the C2C, the Case-to-Closure platform that you've just mentioned. Maybe talk about the early adoption you might be seeing among the other public sector customers? Anything you can add along these lines?

Yeah, absolutely. Look, the C2C, the Case-to-Closure, is clearly in a very early stage. We have -- and this is very encouraging news basically for any Cellebrite investor because with 5,300 public sector customers, the percentage of customers who have deployed, I would say the combination of Inseyets, Guardian and Pathfinder as the total package is currently very small. Now, I would say that we are very optimistic of our installed base of public sector customers and their ability to deploy multiple Cellebrite solutions within the C2C platform, especially as we more tightly integrate. And I spoke about it on the Investors Day, actually investing a lot in streamlining these solutions, not to mention the cloud enablement side-by-side with on-prem. Now, we do believe that the cloud enablement, by the way is part of this, cloud enablement of our solution will make it even easier for customers to adopt more solutions within the C2C platform and we expect further progress on our product roadmap in that direction. I hope that covers your question.

No, absolutely, loud and clear. Thank you for that. I'll leave the floor. I may come back later for additional questions. Congrats.

Thank you.

Thank you.

Our next question is from Brad Zelnick of Deutsche Bank. Your line is open.

Great. Thanks for taking our questions. This is Bob on for Brad and congrats on the solid start to the year. Can you just elaborate a little bit more on Inseyets? And it's great to hear some of the early success that you're seeing there. But just can you give us more elaboration in terms of what drives your confidence that the majority of customers will upgrade over the next few years from UFED to Inseyets? And secondarily, how do we think about the monetization opportunity and the uplift that you might see as customers migrate?

Okay, maybe I'll take it for a start. I'll take it. Look, our goal is to upgrade the vast majority of our installed base to Inseyets over the next three years. And 2024 goal, I would say, is to upgrade more than 10% of our installed base to Inseyets. I must say that I mentioned that, by the way, during my pitch earlier that we launched it actually for the first time in this quarter in full. And I have to say, and I'm glad to say, that the interest in Inseyets is high with very favorable feedback from earlier adopters. And this is, by the way, while we haven't announced any plans to sun-set the legacy, in digital forensic solutions, maybe UFED or the Premium, but it is obviously reasonable to expect that on a timely manner, where we're in sunset, it will basically accelerate the process. The Inseyets may be to deliver considerable more value than the legacy offering. And the higher value obviously enable us, I would say command and enable us higher price tag. That is approximately 20% to 25% higher than the comparable legacy solutions. And we expect that the upgrading the vast majority of the installed base of Inseyets will be completed within the next three years. Maybe last word, there is also the enterprise, the private sector, and for the private sector we also see a good traction as our next generation solution to add the complex data collection requirements for the private sector customers and obviously for the service providers. So I'll stop here. Dana, I don't know if you want to add anything.

No, I think you fully covered the question.

Is it?

Thank you. That was extremely helpful. And just one follow-up form me. Just on kind of some of the go-to-market changes that you're making and kind of broadening the coverage in the US and EMEA, how should we think about the payback period on some of these investments given there are long sales cycles here and then, could there be any disruption as we think about just -- as you optimize sales operation, customer experience, et cetera?

Maybe I'll start. Actually, we have a very solid model on return investment of introducing a new quota carrier. So we have clear internal KPI that we take into consideration. We decide on increasing our quota carrier teams. I would say that a reasonable onboarding period for a quota carrier until we see a high level of return investment is around six months. Inseyets sales may be shorter. So even with the longer sales cycles, we are seeing return investments in a manner of two to three quarters with our quota carriers. We did mention that we are reallocating OpEx to support the increased quota carriers, Americas, EMEA mainly, but also in APAC. But it is also from other activities that we are doing and we can actually do it by introducing efficiencies into our systems processes, compliance, integration and so forth. So we do not see or expect any -- I would say, shortfall on our ability to support the increased business.

Our next question is coming from Jonathan Ho of William Blair.

Hi, good morning and congrats on the strong quarter. I just wanted to understand, just given your strong performance to start the year, why not raise the guidance for the full year? I'm Just trying to understand if there's any deals that came in earlier than anticipated or if there was any movement between the quarters?

So I think, first of all, we started the year by saying that we will start providing quarterly guidance, and this was to enhance our transparency and the ability for the investors and the analysts to have better insights on our plans and our performance. And I'm glad to say that we've done it last quarter, and we are doing it this quarter in a very constant manner. We are at -- off with a solid start, but we have considerably more work to do ahead as Yossi mentioned in his prepared comments. And we believe it's a little bit premature to start changing our outlook at this stage of the year, although we are fairly confident with our guidance and our ability to execute.

Our next question is from Mike Cikos of Needham.

Hey, thanks for taking the questions, guys, and I apologize for any background noise. I wanted to come back to Yossi's prepared remarks, and I think one of my colleagues had asked about Inseyets and this conversion process or upgrade cycle that we're on the cusp of -- can you further elaborate on how Q1 played out with respect to how those conversion rates trended versus your internal plan? As well as I know it's probably early here, but are you guys actually seeing that ASP uplift? I know we're talking about 20% to 25% is what we're expecting, but is that starting to bear out now that we have a full quarter under our belt here?

Well, I would say the following. As I said, I look at it long term and I'll get to 2024 in a second. As I said, we want to in a prospective of three years to upgrade the vast majority of the installed base. And clearly there are some factors that can influence that. For example, one of them, the exact percentage of anticipated conversion can depend on the timing of already existing multi year subscription and obviously certain levels of churn. In Q1 2024, I think you were asking about that. There was good initial progress. We are very satisfied to where we stand, I would say that -- and I think I mentioned that we are expecting an upgrade of more than 10%. So 10% plus basic target, I would say is based on budget cycles. Many customers will build this into their 2025 and into their 2026 budget and clearly, obviously that has been factored to avoid any misunderstanding in our financial expectations and we expect to see an upgrade activity build, I would say during H2 of this year and basically to build the momentum for 2025.

I would say that from the ARPC we are seeing high teens increase in price, which is a great success considering the fact that those early adopters did not include this increase in their budget. So their ability to introduce it in the first year and not wait for it for the second and third year, we find it very, very much encouraging.

Our next question is from Eric Martinuzzi of Lake Street.

Yeah, you talked about gross margin range of 82% to 84%, yet you have the 85.7% non-GAAP gross margin in Q1. Was there anything to call out in Q1 that goes away, so to speak, in forward quarters?

Yeah, I think if you look at the gross margins related to subscription that we provide in the additional financial deck, it's around 7%, 7.5% of cost to subscription. With the further introduction of cloud based and SaaS offering, we expect our costs around subscription to increase over time, especially around hosting and cloud operation. And further, the more we will of the install base of Inseyets will be transitioned to -- from UFED to Inseyets we will see a little bit more of also hardware sales that come with a very marginal gross profit, as such this is why on the full year basis we are talking about 82% to 84%.

We'll take our next question from Brian Essex of JPMorgan.

Hey, good morning and thank you for taking the question. Maybe just a follow-up on Shaul's FedRAMP question, we'd like to know how that's progressing so far, how long you think it will take? And do you think you'd be able to complete the process fast enough to benefit from the 3Q federal spending cycle this year? Or is that a longer-term issue more to benefit growth in the following years?

I would say that we expect, I would say to finish the process or that initiative in the first half of 2025 with audit to be ready by end of 2024. That means that we will be able the way we -- and I have to say that we are standing very well right now. We published about the process that we do with Coalfire in order to build the site and the testing and the applicative part. And I can also say that we have a sponsor and even more than one as part of the process. Meaning that if all goes well, audit end of 2024. It means that we can embed that into discussions with customers about business in 2025 and finishing the process in the first half of 2025.

Great. Super helpful. Maybe just a follow-up, Yossi, in your prepared remarks, you talked about expanding exposure to the private sector, and particularly you called out, I believe, a Fortune-200 waste management provider replacing incumbent solutions there. Maybe a little -- could you offer a little color in terms of what you replaced and how applicable this will be to other customers within the private sector?

Absolutely. First of all, maybe as a generic statement, private sector revenue and ARR performed, I would say reasonably well in the beginning of the year, by the way same as it was last year and over the past six months. And I mentioned one leadership position, we actually upgraded two positions, Q4 '23, a new sales leader as part of the CRO organization and the new Head of Enterprise Solution, actually in the beginning of Q2 2024. So I have to say that we are optimistic that we will achieve our targets for the private sector revenue and ARR for 2024. And maybe on top of that, the focus here, and you were asking about the Fortune 250. That customer that I mentioned is part of the Fortune 250. We are clearly targeting blue chip enterprises and large and mid-sized service providers. We are targeting to mainly to -- the prestigious industries where the element of eDiscovery internal corporate investigations is critical and meaningful. So that's part of that effort. Again, major focus is to be what we are, world champ in advanced and remote advanced collection. On top of that, I'm glad to say that recently we also executed a strategic review of that entire segment with some clear vectors of progress into the near and mid-term future, that makes us also more confident. So I hope I gave enough view on that.

We'll take our next question from Jeff Van Rhee of Craig-Hallum.

Great, thanks for taking my questions. Yossi, just along the levels of, kind of the high level outlook and the second half embedded in the guide. How is your macro thinking evolved in the last 90 to 180 days?

Generally about the -- I would say the macro environments of the market?

Yes.

Look, I'm glad to say that -- I'll split it, obviously the major focus is related to the public sector. And over there I would say that everything that we had anticipated in terms of factors and drivers remain the same. The market is healthy. The drivers that we spoke, which are pushing our technology in the context of destructive technology is there and the spending of our customers are anticipated to stay the way they are with even additional possibility of upside. That statement is valid, I would say, both for the state and local government and for the federal. In that context, by the way, maybe worth emphasizing that, I'm talking about spending. We need to remember that in that relatively healthy environment, the spending on Cellebrite at the moment is really fraction of what those customers spend. So we have pretty much, I would say a secure ground to believe that's what we are anticipating to developer to execute will be according to what we plan. I hope that helps.

It does. Understood. And if I could, one other question on the new logo front, understanding the opportunities go into the base and upsell, but looking at the new logos, are there any lessons to be learned there in terms of the effectiveness of the C2C platform or Inseyets in terms of higher win rates, broader adoption at initial purchase? Any observations there?

As I said to the -- I would like basically to split my answer. The element we have in the public sector, 5,300 agencies. Within those 5,300 agencies there is a large amount of large -- what we call strategic and mid-high prime accounts. And over there our -- and I mentioned that in my opening there are many sub-logos, new buying centers, untapped buying centers, untapped professional centers within that logo. So if I go back right now to the C2C, one good news, early stage. Second, the ability, basically, while streamlining it and while bringing more value between the three flagships, the Inseyets, collect and review on the front end. The access on the front end. The Pathfinder, AI-based analytics on the back end. And the bridge with evidence management and case management, and the streamline between them, enable us and will enable us more and more to penetrate in more sub-logos/ profit centers/buying centers. The good news, we are in an early stage, but I'm glad to see. I would say that if I look at our pipe, the amount or the cases, especially by the large and mid-sized customers, that we see more than one or two solutions based on that combination is increasing dramatically. Especially, by the way, on the state and local government side.

Got it. Very helpful. Thank you.

We'll take our next question from Louie DiPalma of William Blair.

Yossi, Dana and Andy. Good morning.

Good morning.

Hi.

It seems price is expected to be a significant driver of growth over the next three to five years. And are there three primary upgrades taking place for the installed base of 32,000 licenses? First is there the Inseyets upgrade, and then the C2C upgrade for the end-to-end ecosystem. And then third, the on-premise upgrade to the cloud. And do all three of these upgrades involve higher pricing for the increased value that you're providing?

I think that if we look at the long term model, Louie, the main driver of our expansion in the coming years will be really linked to the increased digital data that our customers need to process. So either you can call it a price increase because the Inseyets now can do double the work and much more efficiency -- but -- with much more efficiencies. So actually, we are setting more capacity with the same number of licenses in a reasonably higher price. Or you can actually look at the expansion that we are looking to do within the investigative units with Pathfinder and the Guardian that I think we discussed in the past, we believe that this market can grow 35% to 50% year-over-year. So these are the main two drivers. The ongoing price increase of the same offering, year-over-year, I would say, baked into -- our model, is around 4%. So this is not the main issue. And Inseyets is not a price increase. It's a different offering with a different value and a different tag price in our point of view. I hope this was helpful.

Great. Yes, and you reached a 20% EBITDA margin in the first quarter, which is typically, Dana, your lowest margin quarter. Is this 20% margin sustainable going forward, even with the increased headcount and investments? And should margins be like smoother on a quarter-to-quarter basis going forward than they have been in the past?

We believe that throughout the years we will see smoother margins quarter-to-quarter, because with the transition to subscription, we'll see also smoother revenue increase which will be aligned with the marginal increase in OpEx quarter-over-quarter. Our model speaks about 20% plus EBITDA in the mid-term. We are very, very satisfied with Q1, but Q1 was not fully representing our OpEx plans for the full year in a nutshell. Yeah.

That makes sense. Thanks everyone.

[Operator Instructions] We'll take a question from Tomer Zilberman of Bank of America.

Hey guys, maybe just one quick one, to touch up on an earlier question. Can you just talk about how much visibility you have into demand for the remainder of the year? Less on expectations to the guidance, but how much visibility can you see?

So, when we look in the opportunity management process that we have in the Company, we have a great visibility into the coming two quarters, so, Q2 and Q3. And I would say which makes us very confident in our ability to deliver the full year. That's in a nutshell.

Got it. Thank you.

We do have a follow-up question from Mike Cikos of Needham. Your line is open.

Thanks for getting me back on here, guys. I did just want to follow-up. I know that [Technical Difficulty] how you expect an acceleration in upgrade activity in the back half of this year and into calendar '25, which makes sense intuitively as customers are building in additional budget. But I just wanted to get a better sense. When we think about the guidance that you have constructed today, is that acceleration embedded in the guide, or is that seen as more of a potential upside catalyst?

The 10% plans is embedded in our plans for the year, the budgets for next year. While we will see the opportunity start to build this year, most of them will be realized in '25.

Okay. And with the, I know Marcus, your new Chief Revenue Officer, did a great job at the Investor Day in March, but just imagine that he's been charged with helping in some way accelerate [Technical Difficulty] to build that budget, right. To help your conversions. Is that where we should think about driving towards when you look at the hires in the go-to-market effort around, whether it's pre-sales or instituting some of these different sales operations that you guys have, is that a fair characterization or is there anything else that we're missing there?

Mike, I'm not sure that I understand the question, but at least I'll try. First of all, I would agree completely with the statement that Marcus has done and is doing and will do a great job. But putting that aside, the focus is on functionality wise. The focus is on a strong mix between quota carriers and post-sale customer success, which are the two major direction and vectors where we are going to invest the money. And in generally, there is a potential for acceleration.

I guess. Thanks for that. Sorry to be mixed up on the question here. I guess, is there a way for Cellebrite to help customers accelerate their internal process to help get that budget sooner for this upgrade, right. Are you able to do anything on that front to help them get additional funding for Cellebrite? I'm hoping that question makes sense.

Okay. It makes sense, and there are possibilities in that direction. There are cases that, there are special grants, which are being created by customers. End of last year, by the way, we hired for the first time people in the area of grant management which are doing exactly that. And that enables us to support them to create those extra grants and create additional budget opportunities.

This concludes the question-and-answer portion of today's call. I would now like to turn the floor over to Cellebrite CEO, Yossi Carmil for additional or closing remarks.

I would like to thank you again, all for participating. Thank you also for the interest and the trust in Cellebrite. And above all, I would like to thank my colleagues, the Cellebrite employees, for performing this for Q1. And well done, and good luck to us for the rest of the year. Thank you.

Thank you. This concludes today's Cellebrite first quarter 2024 financial results conference call. Please disconnect your line at this time and have a wonderful day.